Related Experiment Video
Updated: Aug 17, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
Published on: April 28, 2022
Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as
Nicholas M Selby1, Sally Fonseca, Lisa Hulme
1Department of Renal Medicine, Derby City Hospital, Uttoxeter Road, Derby DE22 3NE, UK.
Insights
High glucose concentrations in continuous ambulatory peritoneal dialysis (CAPD) fluids significantly increase blood pressure by raising cardiac output. These hemodynamic changes may negatively impact patient outcomes.
Area of Science:
- Nephrology
- Cardiovascular Physiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is widely used for end-stage renal failure.
- Hemodynamic effects of CAPD, particularly with glucose-based solutions, are not well understood.
Purpose of the Study:
- To investigate the hemodynamic effects of CAPD using different glucose concentrations and icodextrin.
- To assess the impact of these fluids on blood pressure and cardiac function.
Main Methods:
- Prospective crossover study involving eight CAPD patients.
- Non-invasive measurement of blood pressure and hemodynamic variables (HR, SV, CO, TPR) during dwells with 1.36% glucose, 3.86% glucose, and 7.5% icodextrin.
Main Results:
- Blood pressure was significantly higher with 3.86% glucose dwells compared to 1.36% glucose or icodextrin.
- Increased heart rate, stroke volume, and cardiac output contributed to higher blood pressure with 3.86% glucose.
- Total peripheral resistance remained similar across all fluid types.
Conclusions:
- CAPD fluids with high glucose concentrations induce significant hemodynamic changes.
- These changes, including elevated blood pressure and cardiac output, may have adverse long-term consequences for CAPD patients.
- Beyond glycemic control and peritoneal membrane effects, CAPD fluid composition impacts systemic hemodynamics.
Background:
Little is known about the haemodynamic effects of continuous ambulatory peritoneal dialysis (CAPD) despite its widespread use in the management of end-stage renal failure. We undertook a study to delineate the haemodynamic effects of CAPD using glucose-containing fluids (1.36 and 3.86% glucose) and icodextrin.
Methods:
Eight CAPD patients were recruited for a prospective crossover study. Patients attended for two investigatory days (in random order). CAPD was carried out using 1.36% followed by 3.86% glucose (buffered with lactate/bicarbonate, Physioneal) on one study day and 1.36% glucose followed by 7.5% icodextrin (Extraneal) on the other day. Dwell times were 150 min. Blood pressure (BP) and a full range of haemodynamic variables including pulse (HR), stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were measured non-invasively using continuous arterial pulse wave analysis.
Results:
BP was significantly higher during 3.86% glucose dwells as compared with 1.36% glucose or icodextrin dwells (P<0.0001). TPR during all three dwells was similar; the higher blood pressure was due to an increased HR, SV and, therefore, CO during 3.86% glucose dwells. The higher blood pressure during the 3.86% glucose dwells was present despite the highest ultrafiltration volume and sodium removal.
Conclusion:
This study demonstrates large magnitude haemodynamic changes in response to CAPD. In addition to the well-recognized adverse effects on blood glucose and long-term peritoneal membrane viability, CAPD fluids containing high glucose concentrations may also exert undesirable effects on systemic haemodynamics, with potential long-term consequences for patient outcomes.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Hyperglycemia
Hyperosmolar Hyperglycemic State
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Osmosis and Osmotic Pressure of Solutions
